세계 핸드헬드 수술 기기 시장 예측(-2030년)

Market Overview

Handheld Surgical Devices Market is anticipated to register a CAGR of 5.42% during the forecast period.

The developing instances of chronic diseases, for example, cardiovascular, neurological, urological, and irresistible sicknesses and expanding utilization of handheld devices in negligibly obtrusive medical procedures are central point driving the development of the Handheld Surgical Devices Market.

Ongoing illnesses, for example, cardiovascular, neurological, urological, and irresistible infections are expanding all around the world. Heart issues are turning out to be more normal than other constant illnesses because of an absence of active work, being overweight, smoking, unfortunate sustenance, or having a family ancestry. Moreover, diabetes, hypertension, and hyperlipidemia are all chance elements for cardiovascular illness. Individuals beyond 60 a year old at a higher gamble of creating illnesses, for example, cardiovascular, muscular, and neurological issues. Certain individuals with these circumstances or infections should go through a medical procedure. Consequently, an expansion in cardiovascular, muscular, and neurological issues is supposed to help the interest for handheld surgical devices. The utilization of great devices by specialists is a steady need to execute medical procedures effectively and rapidly without compromising the strength of the patient. Consequently, factors that are causing a flood in the requirement for handheld surgical devices incorporate the rising commonness of ongoing circumstances like cardiovascular, neurological, urological, and irresistible illnesses.

Segment Insights

The Handheld Surgical Devices Market segmentation, based on product type, includes graspers, retractors, mechanical cutters, suction tips and tubes, irrigation and injection needs, scopes and probes, sutures, forceps, tweezers, and others.

Based on application, the Handheld Surgical Devices Market includes orthopedic surgery, ophthalmology, cardiology, wound care, urology and gynecology surgery, plastic surgery, thoracic surgery, neurosurgery, and others. The end user segment includes hospitals & clinics, ambulatory surgical centers, and others.

Regional Insights

The North America handheld surgical devices market represented the biggest market share in 2022. The North America regional market is the biggest market with regards to income. The market is driven by the rising pervasiveness of cardiovascular, malignant growth, neurological, and immune system problems around here.

Europe handheld surgical ventures accounted for the second-biggest market share because of the developing interest for safe surgical devices that are utilized in negligibly obtrusive medical procedures, rising innovative work speculations, and expanding geriatric populace. Moreover, the Germany handheld surgical devices market credited to hold the biggest market share, and the France handheld surgical devices market is extended be the quickest developing market in the Europe area.

The Asia-Pacific handheld surgical devices market is supposed to be the quickest developing from 2023 to 2030 because of the developing populace, the rising spending force of purchasers, and the high commonness of persistent problems.

Major Players

Key Companies in the handheld surgical devices market includes Zimmer Biomet Holdings Inc. (US), Braun Melsungen AG (Germany). Becton, Dickinson and Company (US), Medline Industries Inc. (US), Peter Surgical (France), Medtronic Plc (Ireland), Abbott (US), Boston Scientific Corporation (US), Stryker (US), Smith & Nephew (UK), Coloplast Corp. (Denmark), Terumo Medical Corporation (Japan), Integra Lifesciences Holdings Corporation (US), Olympus Corporation (Japan), and Johnson & Johnson Services, Inc. (US).

TABLE OF CONTENTS

TABLE OF CONTENTS

1 EXECUTIVE SUMMARY

• 1.1 OVERVIEW
  • 1.1.1 MARKET SYNOPSIS

2 MARKET INTRODUCTION

• 2.1 DEFINITION
• 2.2 SCOPE OF THE STUDY
• 2.3 RESEARCH OBJECTIVE
• 2.4 LIST OF ASSUMPTIONS

3 RESEARCH METHODOLOGY

• 3.1 OVERVIEW
• 3.2 DATA MINING
• 3.3 SECONDARY RESEARCH
• 3.4 PRIMARY RESEARCH
  • 3.4.1 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS
  • 3.4.2 BREAKDOWN OF PRIMARY RESPONDENTS
• 3.5 FORECASTING TECHNIQUES
• 3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION
  • 3.6.1 BOTTOM-UP APPROACH
  • 3.6.2 TOP-DOWN APPROACH
• 3.7 DATA TRIANGULATION
• 3.8 VALIDATION

4 MARKET DYNAMICS

• 4.1 OVERVIEW
• 4.2 DRIVERS
  • 4.2.1 THE GROWING PREVALENCE OF CHRONIC DISORDERS, SUCH AS CARDIOVASCULAR, NEUROLOGICAL, UROLOGICAL, AND INFECTIOUS DISEASES
  • 4.2.2 INCREASING USE OF HANDHELD DEVICES IN MINIMALLY INVASIVE SURGERIES
• 4.3 RESTRAINTS
  • 4.3.1 COMPETITIVE PRICING AMONG COMPETITORS
• 4.4 OPPORTUNITIES
  • 4.4.1 GROWING DEMAND FOR AESTHETIC SURGERIES

5 MARKET FACTOR ANALYSIS

• 5.1 VALUE CHAIN ANALYSIS
  • 5.1.1 R&D
  • 5.1.2 MANUFACTURING
  • 5.1.3 DISTRIBUTION & SALES
  • 5.1.4 POST-SALES MONITORING
• 5.2 PORTER'S FIVE FORCES MODEL
  • 5.2.1 THREAT OF NEW ENTRANTS
  • 5.2.2 BARGAINING POWER OF SUPPLIERS
  • 5.2.3 THREAT OF SUBSTITUTES
  • 5.2.4 BARGAINING POWER OF BUYERS
  • 5.2.5 INTENSITY OF RIVALRY
• 5.3 IMPACT OF COVID-19 ON THE GLOBAL HANDHELD SURGICAL DEVICES MARKET
  • 5.3.1 IMPACT ON SUPPLY CHAIN
  • 5.3.2 IMPACT ON KEY PLAYERS
• 5.4 LIST OF CONTACT INFORMATION FOR KEY PERSONNEL IN THE US
• 5.5 KEY MANUFACTURERS AND THEIR TOTAL NUMBER OF MANUFACTURING PLANTS/ FACTORIES IN THE US

6 GLOBAL HANDHELD SURGICAL DEVICES MARKET, BY PRODUCT TYPE

• 6.1 OVERVIEW
• 6.2 GRASPERS
• 6.3 RETRACTORS
• 6.4 MECHANICAL CUTTERS
• 6.5 SUCTION TIPS AND TUBES
• 6.6 IRRIGATION AND INJECTION NEEDS
• 6.7 SCOPES AND PROBES
• 6.8 SUTURES
• 6.9 FORCEPS
• 6.10 TWEEZERS
• 6.11 OTHERS

7 GLOBAL HANDHELD SURGICAL DEVICES MARKET, BY APPLICATION

• 7.1 OVERVIEW
• 7.2 ORTHOPAEDIC SURGERY
• 7.3 OPHTHALMOLOGY
• 7.4 CARDIOLOGY
• 7.5 WOUND CARE
• 7.6 UROLOGY AND GYNAECOLOGY SURGERY
• 7.7 PLASTIC SURGERY
• 7.8 THORACIC SURGERY
• 7.9 NEUROSURGERY
• 7.10 OTHERS

8 GLOBAL HANDHELD SURGICAL DEVICES MARKET, BY END USER

• 8.1 OVERVIEW
• 8.2 HOSPITALS & CLINICS
• 8.3 AMBULATORY SURGICAL CENTERS
• 8.4 OTHERS

9 GLOBAL HANDHELD SURGICAL DEVICES MARKET, BY REGION

• 9.1 INTRODUCTION
• 9.2 NORTH AMERICA
  • 9.2.1 US
  • 9.2.2 CANADA
• 9.3 EUROPE
  • 9.3.1 GERMANY
  • 9.3.2 FRANCE
  • 9.3.3 UK
  • 9.3.4 ITALY
  • 9.3.5 SWEDEN
  • 9.3.6 SPAIN
  • 9.3.7 REST OF EUROPE
• 9.4 ASIA-PACIFIC
  • 9.4.1 JAPAN
  • 9.4.2 CHINA
  • 9.4.3 INDIA
  • 9.4.4 AUSTRALIA
  • 9.4.5 SOUTH KOREA
  • 9.4.6 REST OF ASIA PACIFIC
• 9.5 REST OF THE WORLD
  • 9.5.1 MIDDLE EAST
  • 9.5.2 AFRICA
  • 9.5.3 LATIN AMERICA

10 COMPETITIVE LANDSCAPE

• 10.1 OVERVIEW
• 10.2 COMPETITIVE BENCHMARKING
• 10.3 MAJOR GROWTH STRATEGY IN THE GLOBAL HANDHELD SURGICAL DEVICES MARKET
• 10.4 THE LEADING PLAYER IN TERMS OF THE NUMBER OF DEVELOPMENTS IN THE GLOBAL HANDHELD SURGICAL DEVICES MARKET
• 10.5 KEY DEVELOPMENT ANALYSIS
• 10.6 KEY DEVELOPMENTS & GROWTH STRATEGIES
  • 10.6.1 PRODUCT/COMPANY LAUNCH/PRODUCT APPROVAL
  • 10.6.2 MERGER/ACQUISITION

11 COMPANY PROFILES

• 11.1 JOHNSON & JOHNSON SERVICES, INC.
  • 11.1.1 COMPANY OVERVIEW
  • 11.1.2 FINANCIAL OVERVIEW
  • 11.1.3 PRODUCTS OFFERED
  • 11.1.4 KEY DEVELOPMENTS
  • 11.1.5 SWOT ANALYSIS
  • 11.1.6 KEY STRATEGIES
• 11.2 ZIMMER BIOMET HOLDINGS INC.
  • 11.2.1 COMPANY OVERVIEWS
  • 11.2.2 FINANCIAL OVERVIEW
  • 11.2.3 PRODUCTS/SERVICES OFFERED
  • 11.2.4 KEY DEVELOPMENTS
  • 11.2.5 SWOT ANALYSIS
  • 11.2.6 KEY STRATEGIES
• 11.3 B. BRAUN MELSUNGEN AG
  • 11.3.1 COMPANY OVERVIEW
  • 11.3.2 FINANCIAL OVERVIEW
  • 11.3.3 PRODUCTS OFFERED
  • 11.3.4 KEY DEVELOPMENTS
  • 11.3.5 SWOT ANALYSIS
  • 11.3.6 KEY STRATEGIES
• 11.4 INTEGRA LIFESCIENCES HOLDINGS CORPORATION
  • 11.4.1 COMPANY OVERVIEW
  • 11.4.2 FINANCIAL OVERVIEW
  • 11.4.3 PRODUCTS OFFERED
  • 11.4.4 KEY DEVELOPMENTS
  • 11.4.5 SWOT ANALYSIS
  • 11.4.6 KEY STRATEGIES
• 11.5 MEDTRONIC PLC
  • 11.5.1 COMPANY OVERVIEW
  • 11.5.2 FINANCIAL OVERVIEW
  • 11.5.3 PRODUCTS OFFERED
  • 11.5.4 KEY DEVELOPMENTS
  • 11.5.5 SWOT ANALYSIS
  • 11.5.6 KEY STRATEGIES
• 11.6 BECTON, DICKINSON, AND COMPANY
  • 11.6.1 COMPANY OVERVIEW
  • 11.6.2 FINANCIAL OVERVIEW
  • 11.6.3 PRODUCTS OFFERED
  • 11.6.4 KEY DEVELOPMENTS
  • 11.6.5 KEY STRATEGIES
• 11.7 BOSTON SCIENTIFIC CORPORATION
  • 11.7.1 COMPANY OVERVIEW
  • 11.7.2 FINANCIAL OVERVIEW
  • 11.7.3 PRODUCTS OFFERED
  • 11.7.4 KEY DEVELOPMENTS
  • 11.7.5 KEY STRATEGIES
• 11.8 STRYKER
  • 11.8.1 COMPANY OVERVIEW
  • 11.8.2 FINANCIAL OVERVIEW
  • 11.8.3 PRODUCTS OFFERED
  • 11.8.4 KEY DEVELOPMENTS
  • 11.8.5 KEY STRATEGIES
• 11.9 SMITH AND NEPHEW
  • 11.9.1 COMPANY OVERVIEW
  • 11.9.2 FINANCIAL OVERVIEW
  • 11.9.3 PRODUCTS OFFERED
  • 11.9.4 KEY DEVELOPMENTS
  • 11.9.5 KEY STRATEGIES
• 11.10 MEDLINE INDUSTRIES, INC.
  • 11.10.1 COMPANY OVERVIEW
  • 11.10.2 FINANCIAL OVERVIEW
  • 11.10.3 PRODUCTS OFFERED
  • 11.10.4 KEY DEVELOPMENTS
  • 11.10.5 KEY STRATEGIES
• 11.11 ABBOTT
  • 11.11.1 COMPANY OVERVIEW
  • 11.11.2 FINANCIAL OVERVIEW
  • 11.11.3 PRODUCTS OFFERED
  • 11.11.4 KEY DEVELOPMENTS
  • 11.11.5 SWOT ANALYSIS
  • 11.11.6 KEY STRATEGIES
• 11.12 PETERS SURGICAL
  • 11.12.1 COMPANY OVERVIEW
  • 11.12.2 FINANCIAL OVERVIEW
  • 11.12.3 PRODUCTS OFFERED
  • 11.12.4 KEY DEVELOPMENTS
  • 11.12.5 KEY STRATEGIES
• 11.13 COLOPLAST CORP.
  • 11.13.1 COMPANY OVERVIEW
  • 11.13.2 FINANCIAL OVERVIEW
  • 11.13.3 PRODUCTS OFFERED
  • 11.13.4 KEY DEVELOPMENTS
  • 11.13.5 KEY STRATEGIES
• 11.14 TERUMO MEDICAL CORPORATION
  • 11.14.1 COMPANY OVERVIEW
  • 11.14.2 FINANCIAL OVERVIEW
  • 11.14.3 PRODUCTS OFFERED
  • 11.14.4 KEY DEVELOPMENTS
  • 11.14.5 KEY STRATEGIES
• 11.15 OLYMPUS CORPORATION
  • 11.15.1 COMPANY OVERVIEW
  • 11.15.2 FINANCIAL OVERVIEW
  • 11.15.3 PRODUCTS/SERVICES OFFERED
  • 11.15.4 KEY DEVELOPMENTS
  • 11.15.5 KEY STRATEGIES

12 APPENDIX

• 12.1 REFERENCES
• 12.2 RELATED REPORTS